Related Experiment Video

Updated: Aug 31, 2026

Using In Vivo and Tissue and Cell Explant Approaches to Study the Morphogenesis and Pathogenesis of the Embryonic and Perinatal Aorta
10:57

Using In Vivo and Tissue and Cell Explant Approaches to Study the Morphogenesis and Pathogenesis of the Embryonic and Perinatal Aorta

Published on: September 12, 2017

A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickening

Muzharul M Islam1, Christopher D Franco, David W Courtman

  • 1Departments of Laboratory Medicine and Pathobiology and Medicine, University of Toronto, Toronto, Ontario, Canada.

The American Journal of Pathology
|September 26, 2003
PubMed

Insights

Chemically modified tetracyclines like CMT-3 reduce arterial intimal thickening by inhibiting smooth muscle cell proliferation, migration, and matrix metalloproteinase (MMP) activity. These effects are linked to MMP inhibition, not antibiotic properties.

Area of Science:

  • Vascular biology
  • Pharmacology
  • Biochemistry

Background:

  • Tetracyclines, including doxycycline, inhibit matrix metalloproteinases (MMPs) and affect cellular functions.
  • The specific mechanisms behind doxycycline's inhibition of intimal thickening are unclear, potentially involving antibiotic, anti-MMP, or other actions.
  • Chemically modified tetracyclines (CMTs) were developed to separate antibiotic and anti-MMP activities.

Purpose of the Study:

  • To investigate the effects of CMT-3 (retains anti-MMP activity) and CMT-5 (lacks both antibiotic and anti-MMP activity) on intimal thickening after arterial injury.
  • To determine whether the anti-intimal thickening effects of tetracyclines are dependent on their antibiotic or anti-MMP properties.

Main Methods:

  • Rats underwent balloon catheter injury to the carotid artery.
  • Rats were orally treated with CMT-3 or CMT-5 (15 mg/kg/day).
  • Intimal thickening, smooth muscle cell (SMC) proliferation and migration, MMP activity (specifically MMP-2), and extracellular matrix accumulation were assessed.

Main Results:

  • CMT-3 significantly reduced SMC proliferation in the injured carotid artery compared to CMT-5.
  • CMT-3 inhibited SMC migration by 86% and decreased MMP-2 activity.
  • CMT-3 treatment led to a significant reduction in intimal cross-sectional area and decreased elastin and collagen accumulation.

Conclusions:

  • CMT-3 attenuates intimal thickening post-arterial injury by inhibiting SMC proliferation, migration, MMP activity, and extracellular matrix accumulation.
  • The observed inhibitory effects of CMT-3 are independent of antibiotic properties but dependent on its anti-MMP activity.
  • This suggests that targeting MMPs with specific tetracycline derivatives is a viable strategy for preventing vascular remodeling.

More Related Videos

Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery09:41

Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery

Published on: December 23, 2014

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application06:53

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...